RE:Theralase current statusI think Theralase is doing great and that we will be happy with the phase 2 results despite the false start. Dr. Lilge is a perfectionist and is doing everything in his power to optimize the treatment. He keeps pushing because "good enough" is just not part of his vocabulary.
NorCalTommy wrote: Sorry i haven't been following the message board for awhile but love the TLT story, recently had a big position and hopefully buying back soon... I came across your post Eoganacht... and i found myself wondering if the Theralase story is still as exciting and ready to pop, with the obstacles you mention below regarding Photosensitizer uptake... is this considered a new discovery, did they not know this all along? Is TLT running into obstacles and conditions that they had not completely considered and factored into their therapy, or am i just making too much out of this excerpt below? Is it going to take a host of different applications/procedures by TLT instead of a much more defined and 2x per year frequency treatement that seemed uber elegant and very simple..... now it appears that there are lots of variables.... but again i am not close to expert on these therapies... so i would be very interested in your take (Fred, Cancer Slayer, EOG, and the 'extremely knowledgeable crowd') on how you believe TLT is currently doing? are they 'on plan' or in the middle of 'course corrections/mods/revs' to make the PDT treatment more effective??
Thanks immensely in advance!!
EOGANACHT's Post Excerpt:
It’s acknowledged that the inter- and intra-patient variability of the tissue optical properties and the photosensitizer uptake remains a major obstacle to fully exploit the dual selectivity of PDT, resulting even with the application of precision PDT treatment planning in highly variable treatment outcomes. Enabling personalized PDT treatment planning requires the ability to quantify or predict the locally variable tissue optical properties, photosensitizer accumulation and oxygen availability